Why the study?
Do anti-embolic devices reduce death or reinfarction compared to standard PCI in patients with acute myocardial infarction?
Do anti-embolic devices reduce death or reinfarction compared to standard PCI in patients with acute myocardial infarction?
The use of anti-embolic devices during PCI for acute myocardial infarction does not decrease early mortality or reinfarction compared to standard PCI.
No takes yet. Share an insight, caveat, or question.
No routine use of anti-embolic devices in AMI PCI; confirms absence of benefit on death or reinfarction in Level 1 evidence.
Kunadian et al. (2007) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: